• Policy
• Gov't “will reinvestigate overused reimbursed items”
• by Lee, Jeong-Hwan Aug 24, 2022 05:55am

• Company
• Celltrion Applies to Europe for IND to designate Yuflyma
• by Aug 24, 2022 05:55am

• Product
• There are about 2,300 pharmacies dedicated to COVID-19
• by Jung, Heung-Jun Aug 24, 2022 05:55am

• Policy
• Na Kyung-won is considering being the Minister of Health
• by Lee, Jeong-Hwan Aug 23, 2022 06:04am

• Policy
• Bill for 'state compensation for Paxlovid's side effects'
• by Lee, Jeong-Hwan Aug 23, 2022 06:04am

• Policy
• When will the CSO reporting system be legislated?
• by Lee, Jeong-Hwan Aug 23, 2022 06:04am

• Policy
• There is no concern about the disposal of COVID-19 PO tx
• by Lee, Jeong-Hwan Aug 23, 2022 06:03am

• Company
• Omega-3 prescription market doubles in 3 Years
• by Kim, Jin-Gu Aug 23, 2022 06:03am

• Company
• Abilify 1mg can be prescribed at tertiary hospitals
• by Eo, Yun-Ho Aug 22, 2022 05:53am

• Policy
• “Bio-vaccine fund will be created within the year”
• by Lee, Jeong-Hwan Aug 22, 2022 05:53am